Beta
Gemifloxacin
medication Under reviewA broad-spectrum fluoroquinolone antibiotic used to treat bacterial respiratory tract infections.
Research summary
The healthy-subject literature on gemifloxacin is largely phase 1 pharmacology research rather than supplement-style wellness research. These studies consistently show measurable systemic exposure after oral dosing, good soft-tissue penetration, and generally acceptable short-term tolerability in healthy volunteers. Evidence for any health benefit in healthy people is essentially absent because gemifloxacin is a prescription antibiotic intended for infections, not a preventive or performance supplement. The main human safety signals documented in healthy volunteers include mild headache and, in some studies and regulatory materials, rash; no evidence supports routine use for general health optimization.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Gemifloxacin to your stack to report effects
Gemifloxacin
Balfour and Wiseman
Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose
Wise et al.
No reports yet
Be the first to report this effect and help the community.
Add Gemifloxacin to your stack to report effects
Gemifloxacin
Balfour and Wiseman
Research (2 studies)
Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose
Wise et al.
Gemifloxacin
Balfour and Wiseman
Community updates
No updates yet for this supplement.
Be the first to share your experience!